Diabetes drug cream may offer safer melasma solution
NCT ID NCT07485777
First seen Apr 07, 2026
Summary
This study tests whether a cream made from 30% metformin, a common diabetes drug, can treat facial melasma better and with fewer side effects than the standard Kligman's regimen. About 82 women aged 35-55 with melasma will use either the metformin cream or Kligman's regimen plus sunscreen for 8 weeks. Researchers will measure changes in skin pigmentation and track side effects like redness or burning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA (FACIAL MELASMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fauji Foundation Hospital, Rawalpindi
Rawalpindi, Punjab Province, 44000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.